This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Nooglutyl (Nooglutil)
Obscure Russian glutamate-axis nootropic — N-(5-hydroxynicotinoyl)-L-glutamic acid, developed at the Zakusov State Institute…
Aliases (10)
Overview
What is Nooglutyl (Nooglutil)?
Nooglutyl is a Russian-developed nootropic structurally related to glutamic acid, designed as an AMPA receptor positive modulator and memory enhancer. It is marketed for amnesia, cognitive impairment, and post-stroke recovery in Russia.
Key Benefits
Reported to improve memory acquisition, consolidation, and retrieval in animal models of amnesia. Used clinically in Russia for cognitive deficits associated with brain injury, stroke, and neurodegeneration; limited Western data.
Mechanism of Action
Acts as a positive modulator at AMPA-subtype glutamate receptors, slowing receptor desensitization and prolonging excitatory postsynaptic currents to facilitate long-term potentiation in hippocampal neurons.
▸Brand options4 known
StatusRussian Rx (cerebrovascular insufficiency, MCI, post-stroke cognitive recovery indication per Russian Pharmacological Committee dossier). Unscheduled in US (no FDA registration, no DEA scheduling). Not on EU register. Not on WADA prohibited list. Not a DSHEA-eligible dietary ingredient. Effectively gray-market or specialty Russian-import-only outside CIS.
Peptide Interactions
(in the canonical stack): Generic choline cofactor for any AMPA/cholinergic-adjacent nootropic. Probably useful but not specifically studied with nooglutyl.
(in the canonical stack quarterly): Different mechanism (peptide trophic) — theoretical synergy on the neuroprotective axis. No specific Russian co-prescript…
Significant mechanism overlap (AMPA modulation + neuroprotective framing). Stacking the two is mechanism-redundant. Pick one.
Same logic — partial AMPA + cholinergic mechanism overlap, diminishing returns.
Theoretical pharmacological antagonism with the NMDA-modulator arm. Not empirically studied.
Quality Indicators
Pharmacy-dispensed, intact packaging
Prescription tablets in original sealed packaging from a licensed pharmacy.
Generic vs branded
Generics are usually fine but bioavailability can vary slightly; track if you switch.
Unbranded blister or counterfeit risk
Counterfeit pharmaceuticals are a known issue; verify pharmacy and lot if buying internationally.
What to Expect
- Day 1PK-driven acute peak per administration. Verify dose tolerated.
- Week 1Steady-state reached for most daily-dosed pharma.
- Week 2-4Therapeutic effect established; titration window if needed.
- Long-termPeriodic monitoring per drug class (labs, BP, ECG as applicable).
Side Effects & Safety
- Per Russian sources: Minimal documented adverse effects at therapeutic doses. Occasional mild GI upset, mild headache, mild irritability — generic nootropic-class side effects.
- Western pharmacovigilance signal: Effectively zero (compound is essentially unused outside Russia).
- Rare-serious: No published case reports of serious adverse events. But absence of evidence here is partly absence of exposure — population-scale safety data does not exist.
- Specific watch periods: N/A (no Western clinical use).
Honest framing: Side-effect profile appears clean from Russian sources but the Western evidence base is too thin to make confident safety statements at the population level.
References
Voronina TA et al. — Zakusov Institute nooglutyl pharmacology papers
foundational animal pharmacology, Russian-language primary literature with English abstracts.
View StudySeredenin SB et al. — Zakusov Institute conceptual framing of CMP/PMP balance and Russian nootropic class
institutional context for the Russian nootropic taxonomy.
View StudyRussian Pharmacological Committee — Nooglutyl marketing authorization dossier
basis for Russian Rx authorization in cerebrovascular insufficiency.
View StudyRUPharma — Nooglutyl product page (when in stock)
primary gray-market source, intermittent availability.
View StudyCosmicNootropic — Nooglutyl product page (when in stock)
backup gray-market source.
View Studyr/Nootropics — sparse nooglutyl threads
limited biohacker discussion, mostly mechanism speculation.
View StudyHow was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.